2000年以来,我院对58例肝癌患者应用超声引导经皮穿刺注射无水乙醇治疗,效果良好。报告如下。1 资料与方法1.1 临床资料 58例中,男47例,女11例;年龄41～68岁,平均56.3岁。21例经穿刺抽吸细胞镜检或活检确诊,2例行外科手术组织活检确诊,35例经超声、CT、核磁共振、数字减影及AFP检测确诊。原发性肝癌52例,转移性肝癌6例(乳腺癌4例,胃癌2例)。单结节45例,多结节13例。结节直径1.5～13.8cm。原发性肝癌中,42例合并肝硬化。均无手术切除适应证,天严重心、肝、肾功能损害,结节数目< Since 2000, 58 cases of liver cancer patients with ultrasound-guided percutaneous ethanol injection therapy, the effect is good. The report is as follows. 1 Materials and Methods 1.1 Clinical data 58 cases, 47 males and 11 females; aged 41 to 68 years, mean 56.3 years. Twenty-one patients were diagnosed by biopsy with aspiration and aspiration biopsy. Two patients were confirmed by biopsy and 35 by ultrasound, CT, MRI, digital subtraction and AFP. 52 cases of primary liver cancer, 6 cases of metastatic liver cancer (4 cases of breast cancer, 2 cases of gastric cancer). 45 cases of single nodules, multiple nodules in 13 cases. Nodule diameter of 1.5 ~ 13.8cm. In primary liver cancer, 42 cases were complicated with cirrhosis. No indications for surgical resection, severe heart, liver and kidney dysfunction, the number of nodules <